|
07 May 2019 |
Clover Biopharmaceuticals Receives NMPA Approval for SCB-313 (TRAIL-Trimer) to Initiate Clinical Trials in China
|
|
30 Apr 2019 |
BioVie Achieves Primary Objectives in Phase 2a Clinical Trial of BIV201 in Refractory Ascites
|
|
29 Apr 2019 |
Catalyst Biosciences & Mosaic Biosciences Present Preclinical Data on Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
|
|
28 Apr 2019 |
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
|
|
28 Apr 2019 |
Novo Nordisk receives positive opinion from the European regulatory authorities for Esperoct® (turoctocog alfa pegol, N8-GP) for the treatment of haemophilia A
|
|
26 Apr 2019 |
Novo Nordisk files for EU regulatory approval of oral semaglutide for the treatment of type 2 diabetes
|
|
24 Apr 2019 |
Magenta Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate
|
|
23 Apr 2019 |
Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
|
|
12 Apr 2019 |
89bio Announces Preclinical Data That Demonstrate Potential Utility of BIO89-100 for Treatment of NASH
|
